Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,701 | 166,412 | 495,729 | 336,388 | 332,314 |
| Marketable Securities | 370,450 | 339,209 | 52,368 | 37,736 | 58,597 |
| Receivables | 1,033 | 921 | 876 | 761 | 642 |
| TOTAL | $452,809 | $512,411 | $553,876 | $386,644 | $398,061 |
| Non-Current Assets | |||||
| PPE Net | 2,059 | 2,162 | 2,283 | 2,413 | 2,488 |
| Investments And Advances | 129,985 | 91,195 | 67,097 | 15,242 | 5,484 |
| Other Non-Current Assets | 18,995 | 19,403 | 19,814 | 20,036 | 20,536 |
| TOTAL | $151,039 | $112,760 | $89,194 | $37,691 | $28,508 |
| Total Assets | $603,848 | $625,171 | $643,070 | $424,335 | $426,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,587 | 2,481 | 1,741 | 5,717 | 4,103 |
| Accrued Expenses | 16,714 | 15,763 | 12,853 | 14,075 | 15,958 |
| Other current liabilities | N/A | N/A | N/A | 1,097 | 555 |
| TOTAL | $19,871 | $19,781 | $16,099 | $20,889 | $20,616 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 279,671 | 274,643 | 270,543 | 19,838 | 20,222 |
| TOTAL | $279,671 | $274,643 | $270,543 | $19,838 | $20,222 |
| Total Liabilities | $299,542 | $294,420 | $286,642 | $40,727 | $40,838 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,239 | 28,186 | 27,672 | 27,508 | 27,433 |
| Common Shares | 28 | 28 | 28 | 27 | 27 |
| Retained earnings | -390,562 | -358,008 | -321,753 | -289,215 | -282,549 |
| Other shareholders' equity | -3,861 | -2,434 | -422 | -200 | -176 |
| TOTAL | $304,306 | $330,747 | $356,428 | $383,608 | $385,731 |
| Total Liabilities And Equity | $603,848 | $625,167 | $643,070 | $424,335 | $426,569 |